Rachel Thijssen

Statistics

Publications

Citations

2.6K

H-Index

Active since

1984

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Peter MacCallum Cancer Centre

The Royal Melbourne Hospital

University of Amsterdam

Rachel Thijssen is an author at Walter and Eliza Hall Institute of Medical Research specializing in molecular oncology, life sciences, and chronic lymphocytic leukemia therapy.

ORCID

Publications per year

1984–2024

Publications

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Courtney D. DiNardo, Ing Soo Tiong, Anna Quaglieri et al. · Blood · 2020 · 649 citations · Full text

Medicine, Oncology, Pharmacology +9

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Piers Blombery, Mary Ann Anderson, Jianan Gong et al. · Cancer Discovery · 2018 · 426 citations · Full text

Life Sciences, Genetics, Hematology +10

Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

Richard W. Birkinshaw, Jianan Gong, Cindy S. Luo et al. · Nature Communications · 2019 · 244 citations · Full text

Medicine, Molecular Biology, Oncology +15

Comprehensive characterization of single-cell full-length isoforms in human and mouse with long-read sequencing

Luyi Tian, Jafar S. Jabbari, Rachel Thijssen et al. · Genome biology · 2021 · 228 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Rishu Agarwal, Yih-Chih Chan, Constantine S. Tam et al. · Nature Medicine · 2018 · 204 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 24